 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD
Trial completion date, Trial primary completion date: A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - Aug 15, 2023
P1, N=136, Recruiting, Sponsor: Health Decisions
Trial completion date: May 2023 --> Sep 2024 | Trial primary completion date: May 2023 --> Sep 2024
- | levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD
Enrollment open, Trial completion date, Trial primary completion date: A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - May 24, 2021
P1, N=160, Recruiting, Sponsor: Health Decisions
Trial completion date: May 2023 --> Sep 2024 | Trial primary completion date: May 2023 --> Sep 2024 Not yet recruiting --> Recruiting | Trial completion date: May 2025 --> May 2023 | Trial primary completion date: May 2025 --> May 2023
- | levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD
New P1 trial: A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - Nov 6, 2019
P1, N=128, Not yet recruiting, Sponsor: Health Decisions
- levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD
New P1 trial: A Phase I Study to Evaluate the PK and PD of a Single Injection of Levonorgestrel Butanoate for Female Contraception (clinicaltrials.gov) - Jun 26, 2014
P1, N=16, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)